Your email has been successfully added to our mailing list.

×
0 0 0 0.109324758842444 0.0353697749196143 0.0353697749196143 0.0209003215434085 -0.0396784565916398
Stock impact report

Ziopharm Oncology Reports Second Quarter 2019 Financial Results

ZIOPHARM Oncology Inc (ZIOP) 
Last ziopharm oncology inc earnings: 3/2 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ziopharm.com
Company Research Source: GlobeNewswire
– FDA Cleared IND for Phase 1 Trial of Sleeping Beauty TCR-T cell therapy for patients with solid tumors at the National Cancer Institute (NCI) –– Exclusive license from NCI for library of T-cell receptors (TCRs) targeting neoantigens in the hotspots KRAS, p53 and EGFR –– Balance sheet strengthened with $45 million in proceeds from early warrant exercise –– NCI’s Dr. Drew Deniger to direct TCR program; Sath Shukla named CFO – – Company to host conference call and webcast today at 8:30 a.m. ET – BOSTON, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), a clinical stage immuno-oncology company developing next generation cell and gene therapies, today announced its financial results for the second quarter ended June 30, 2019, and provided an update on the Company’s recent activities. “We have made significant advancements in our programs during the second quarter. The FDA cleared the IND for the first non-viral, neoantigen Show less Read more
Impact Snapshot
Event Time:
ZIOP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ZIOP alerts
Opt-in for
ZIOP alerts

from News Quantified
Opt-in for
ZIOP alerts

from News Quantified